Literature DB >> 27716529

Interaction of curcumin with 1,2-dioctadecanoyl-sn-glycero-3-phosphocholine liposomes: Intercalation of rhamnolipids enhances membrane fluidity, permeability and stability of drug molecule.

Zeinab Moussa1, Mazhar Chebl1, Digambara Patra2.   

Abstract

Stability of curcumin in neutral and alkaline buffer conditions has been a serious concern for its medicinal applications. We demonstrate that the stability of curucmin can be improved in 1,2-Dioctadecanoyl-sn-glycero-3-phosphocholine (DSPC) liposomes. Curcumin strongly partition into liquid crystalline phase compared to solid gel phase of DSPC liposomes. Variation of fluorescence intensity of curcumin associated with liposomes with temperature successfully determines phase transition temperature of DSPC liposomes. However, at higher molar ratio curcumin can influence phase transition temperature by intercalating into deep hydrophobic layer of liposomes and facilitating fusion of two membrane phases. Rhamnolipids (RLs) are recently being applied for various biomedical applications. Here, we have explored new insight on intercalation of rhamnolipids with DSPC liposomes. Intercalation of rhamnolipids exceptionally increases partition of curcumin into solid gel phase of DSPC liposomes, whereas this increase is moderate in liquid crystalline phase. Fluorescence quenching study establishes that permeability and fluidity of the DSPC liposomes are enhanced in the presence of RLs. Membrane permeability and fluidity can be improved further by increasing the percentage of RLs in DSPC liposomes. The phase transition temperature of DSPC liposomes decreases with increase in percentage of RLs in DSPC liposomes by encouraging fusion between solid gel and liquid crystalline phases. Intercalation of RLs is found to further boost stability of drug, curcumin, in DSPC liposomes. Thus, mixing RLs with DSPC liposomes could potentially serve as a good candidate for drug delivery application.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Curcumin; DSPC; Liposomes; Permeability; Phase transition; Rhamnolipids

Mesh:

Substances:

Year:  2016        PMID: 27716529     DOI: 10.1016/j.colsurfb.2016.10.002

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Curcumin Modulates 1,2-dibehenoyl-sn-glycero-3-phosphocholine (DBPC) Liposomes: Chitosan Oligosaccharide Lactate Influences Membrane Fluidity But Does Not Alter Phase Transition Temperature of DBPC Liposomes.

Authors:  Maria Estephan; Riham El Kurdi; Adnan Badran; Elias Baydoun; Digambara Patra
Journal:  J Fluoresc       Date:  2021-10-14       Impact factor: 2.217

2.  Formulation of the novel structure curcumin derivative-loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening in vitro.

Authors:  Ke Li; Chao Pi; Jie Wen; Yingmeng He; Jiyuan Yuan; Hongping Shen; Wenmei Zhao; Mingtang Zeng; Xinjie Song; Robert J Lee; Yumeng Wei; Ling Zhao
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

3.  Rhamnolipid-Based Liposomes as Promising Nano-Carriers for Enhancing the Antibacterial Activity of Peptides Derived from Bacterial Toxin-Antitoxin Systems.

Authors:  Beatriz Cristina Pecoraro Sanches; Camila Aguiar Rocha; Jose Gregorio Martin Bedoya; Vinicius Luiz da Silva; Patrícia Bento da Silva; Ana Marisa Fusco-Almeida; Marlus Chorilli; Jonas Contiero; Edson Crusca; Reinaldo Marchetto
Journal:  Int J Nanomedicine       Date:  2021-02-10

4.  Protective effect of syringic acid via restoring cells biomechanics and organelle structure in human lens epithelial cells.

Authors:  Rong Yang; Xue Li; Jie Mei; Wencheng Wan; Xinduo Huang; Qiaohong Yang; Xiaoyong Wei
Journal:  J Bioenerg Biomembr       Date:  2021-03-11       Impact factor: 2.945

5.  Intraspecies Signaling between Common Variants of Pseudomonas aeruginosa Increases Production of Quorum-Sensing-Controlled Virulence Factors.

Authors:  Dallas L Mould; Nico J Botelho; Deborah A Hogan
Journal:  mBio       Date:  2020-08-25       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.